LA JOLLA, CA — The novel Zio patch (iRhythm Technologies, San Francisco, CA), worn for 14 days, outperformed a conventional Holter monitor worn for 24 hours, in a study of patients who underwent ...

Holter monitors were 1.13 times more likely and AEM were 1.21 times more likely to have a CV event within 1-year compared to Zio LTCM service.

SAN FRANCISCO, April 10, 2017 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focu ...

In this webinar on Feb. 10, healthcare experts from Desert Oasis Healthcare and iRhythm Technologies will discuss how Zio monitors, designed to be worn for longer duration than holter monitors ...

According to a prospective study conducted by Scripps Translational Science Institute (STSI), has found that use of iRhythm Technologies' ZIO Service significantly increased detection of cardiac ...

SAN FRANCISCO, May 18, 2017 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today ...

SAN FRANCISCO, Jan. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC) today announced that the results from the Cardiac Ambulatory Monitor EvaLuation of Outcomes and Time to Events (CAMELOT) study have ...

Barrett P. et al. Comparison of 24-hour Holter monitoring vs. 14-day novel adhesive patch electrocardiographic monitoring. American Heart Journal of Medicine , 2014.

The redesigned Zio patch. (iRhythm) The company said it plans to continue expanding its commercial reach in selected countries on the continent, where about 1.8 million cardiac monitoring tests ...

Zio monitor (Patch ECG Device): Improving Patient Monitoring Experience. ... including other LTCMs and 24- to 48-hour duration Holter monitoring services 6, 8, 15-20 ...

Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups.Latest data ...